CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsAltman Z-Score 10.66: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.77BCNY560.47M · vs all stocks (USD)
Revenue (TTM)
283.34MCNY42.08M · vs all stocks (USD)
Profit Margin
-47.17%Beta
0.0070xvs all stocks
52-Week Change
-24.93%vs all stocks
Market Capitalization
3.77BCNY560.47M · vs all stocks (USD)
Enterprise Value
3.19BCNY473.80M · vs all stocks (USD)
Price to Sales (TTM)
11.29xPrice to Book (MRQ)
1.77xEnterprise to Revenue
11.26xEnterprise to EBITDA
-21.24xGross Margin
13.52%Profit Margin
-47.17%Operating Margin
-95.02%Return on Assets (TTM)
-5.49%Return on Equity (TTM)
-8.72%Revenue (TTM)
283.34MCNY42.08M · vs all stocks (USD)
Revenue per Share (TTM)
0.4300CNYUpdated Aug 20, 2026Quarterly Revenue Growth
24.10%Gross Profit (TTM)
99.58MCNY14.79M · vs all stocks (USD)
EBITDA (TTM)
-150.18MCNY-22.31M · vs all stocks (USD)
Net Income (TTM)
-133.66MCNY-19.85M · vs all stocks (USD)
Operating Cash Flow (TTM)
-225.66MCNY-33.52M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-334.73MCNY-49.71M · vs all stocks (USD)
Payout Ratio
0.00%Minority Interest (Equity)
104.16MCNYFY2025 · Dec 31, 2025Revenue
274.81MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
129.60MCNYFY2025 · Dec 31, 2025Gross Profit
145.21MCNYFY2025 · Dec 31, 2025Operating Income
-142.22MCNY-21.12M · vs all stocks (USD)
Pre-tax Income
-175.53MCNYFY2025 · Dec 31, 2025Income Tax Expense
-14.70MCNYFY2025 · Dec 31, 2025Net Income
-160.83MCNYFY2025 · Dec 31, 2025EBIT
-174.41MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
-79.33MCNYFY2025 · Dec 31, 2025Research & Development
18.87MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
253.89MCNYFY2025 · Dec 31, 2025Other Operating Expenses
6.14MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
4.28MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
1.12MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.1763CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.1763CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
659.58MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
659.58MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-160.83MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
44.55MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-384.72MCNYFY2025 · Dec 31, 2025Free Cash Flow
-560.35MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
203.97MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-160.83MCNYFY2025 · Dec 31, 2025Other Non-cash Items
1.39MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-230.18MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
4.91MCNYFY2025 · Dec 31, 2025Capital Expenditures
-175.63MCNYFY2025 · Dec 31, 2025Sale of Investments
134.55MCNYFY2025 · Dec 31, 2025Other Investing Activity
8.47MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-32.61MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
8.00MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-19.77MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-1.14MCNYFY2025 · Dec 31, 2025Other Financing Charges
-1.12MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-14.03MCNYFY2025 · Dec 31, 2025Shares Outstanding
659.74MSharesUpdated Aug 20, 2026Float Shares
494.57MSharesUpdated Aug 20, 2026% Held by Insiders
36.02%vs all stocks
% Held by Institutions
4.85%vs all stocks
Total Cash (MRQ)
153.88MCNY22.85M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.2330CNYUpdated Aug 20, 2026Total Debt (MRQ)
57.61MCNY8.56M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0302xCurrent Ratio (MRQ)
3.65xBook Value per Share (MRQ)
2.73CNYUpdated Aug 20, 2026Total Assets
2.17BCNY322.05M · vs all stocks (USD)
Total Current Assets
629.34MCNYFY2025 · Dec 31, 2025Total Liabilities
222.00MCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.54BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
31.22MCNYFY2025 · Dec 31, 2025Total Current Liabilities
190.78MCNYFY2025 · Dec 31, 2025Cash
213.39MCNYFY2025 · Dec 31, 2025Cash Equivalents
6.86MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
220.25MCNYFY2025 · Dec 31, 2025Other Short-term Investments
20.10KCNYFY2025 · Dec 31, 2025Accounts Receivable
266.47MCNYFY2025 · Dec 31, 2025Inventory
93.25MCNYFY2025 · Dec 31, 2025Accounts Payable
88.39MCNYFY2025 · Dec 31, 2025Short-term Debt
50.25MCNYFY2025 · Dec 31, 2025Other Current Liabilities
1.72MCNYFY2025 · Dec 31, 2025Long-term Debt
11.19MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
4.94MCNYFY2025 · Dec 31, 2025Common Stock (Book)
229.15MCNYFY2025 · Dec 31, 2025Retained Earnings
559.27MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.95BCNY289.08M · vs all stocks (USD)
52-Week Low
3.04CNYUpdated Aug 20, 202652-Week High
9.25CNYUpdated Aug 20, 202652-Week Change
-24.93%vs all stocks
Beta
0.0070xvs all stocks
50-Day MA
3.57CNYUpdated Aug 20, 2026200-Day MA
6.30CNYUpdated Aug 20, 2026Avg 10-Day Volume
13.20MSharesUpdated Aug 20, 2026Avg 30-Day Volume
9.66MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
-0.2000CNYUpdated Aug 20, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 10.66: safe zoneNotable
Altman Z-Score: 10.66
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Shaanxi Kanghui Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Wuhan Hiteck Biological Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
CHA Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleInterface
Jiangsu Sihuan Bioengineering Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Careray Digital Medical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Boryung Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Assure Tech Hangzhou Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Prime Medicine Inc.
Tier 1ProductionApproval-Gated PipelineRule
Orchid Pharma Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Aohua Photoelectricity Endoscope Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Anbio Biotechnology Limited
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Shandong Longda Meishi Co., Ltd.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Shanghai Geoharbour Construction Group Co. Ltd.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated